SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Donald Trump's escalating threats of new tariffs on European countries, directly linked to his demand to acquire Greenland, are sparking significant market jitters and geopolitical tensions. The community is sharply divided, with many expressing concern over potential trade wars and damaged international alliances, while supporters view these actions as a strong stance for national security and domestic policy. This high-stakes maneuvering continues to fuel intense debate around its economic and diplomatic implications.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending lower in futures trading following renewed tariff threats from former President Trump against Europe over the acquisition of Greenland. This geopolitical escalation has the community deeply divided, with many bears anticipating a significant market sell-off on Tuesday, while bulls are preparing to "buy the dip," expecting a quick recovery or a retraction of the threats. Amidst this uncertainty, safe-haven assets like gold and silver are surging, reflecting broader market anxieties over potential economic disruptions and international trade conflicts.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is surging following an impressive financial report that exceeded expectations and a substantial dividend increase, signaling a robust rebound in investment banking and capital markets activity. This performance is fueling broad bullish sentiment across the financial sector, though some community discussions reflect skepticism and accusations of market manipulation related to a controversial downgrade of another trending stock.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix ($OCUL) is actively trending on reports that Sanofi ($SNY) is preparing an increased takeover offer, following the rejection of an initial $16 per share bid by OCUL's board. This, alongside Ocular's strategic decision to pursue an accelerated FDA submission pathway for its wet AMD drug AXPAXLI based on upcoming Phase 3 data, is driving strong community conviction in a much higher valuation and potential bidding war among major pharmaceutical companies.

Monero

Monero (XMR) is experiencing significant upward momentum, driven by a strong resurgence in the broader privacy coin narrative and its recent attainment of new record highs. The community is actively discussing XMR's fundamental utility as a privacy-by-default cryptocurrency, often highlighting its unique attributes compared to other tokens. This renewed interest reflects a growing recognition of its resilience and value as 'true digital cash' within the market.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to heightened geopolitical tensions after Trump's statements threatening new tariffs on European nations over Greenland, prompting discussions of potential EU retaliatory trade measures. Market participants are divided, with some anticipating a significant pullback, forecasting a "bloody Tuesday," while others expect the market's consistent "buy the dip" strategy to demonstrate resilience. This ongoing trade conflict introduces considerable uncertainty for the technology-heavy index as it navigates a period awaiting clear directional drivers.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance (AERO) is generating significant buzz following its recent listing on a major retail trading platform and ahead of its anticipated "MetaDEX 3.0" event, which includes a proposed merger with Velodrome. As the primary liquidity hub on the growing Base network, the community is actively debating its long-term value accrual, strong fundamentals, and its potential as a dominant cross-chain DeFi player amidst recent price volatility.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund (UNG) is trending amidst a sharp rise in natural gas futures, driven by forecasts for extreme cold weather and expectations of a significant short squeeze. The community is actively discussing the potential for a substantial rally, also noting the long-term demand growth from AI data centers as a supportive factor.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

ONDO is actively discussed as a leader in Real-World Asset (RWA) tokenization, with recent news of the SEC closing its multi-year investigation without charges and gaining EU approval to offer tokenized stocks and ETFs sparking interest. While many in the community are bullish on its institutional partnerships and the long-term potential of bridging traditional finance with blockchain, significant conversation also revolves around concerns over upcoming token unlocks impacting short-term price action. Investors are weighing its foundational role in the RWA sector against potential supply pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Anaphylm is Aquestive’s sublingual epinephrine film for allergic reactions.</li><li>The Anaphylm application is supported by 11 clinical studies involving 411 subjects, the company said.</li><li>Aquestive is working with the agency to better understand and address the issues ahead of the PDUFA date on January 31, it added.</li></ul>Shares of Aquestive Therapeutics (AQST) plunged 40% in pre-market trading on Friday after the company announced that it received a letter from the U.S. Food and Drug Administration (FDA) identifying deficiencies that currently prevent labeling discussions on Anaphylm.Anaphylm is Aquestive’s sublingual (under the tongue) epinephrine film for allergic reactions.However, the FDA also confirmed its review of the New Drug Application (NDA) remains ongoing, and no final decision has been made.Aquestive is working with the agency to better understand and address the issues ahead of the PDUFA (Prescription Drug User Fee Act) date on January 31, noting that delays in receiving details could impact the approval timeline. A PDUFA date is the FDA's target date to make a decision on a drug application.The Anaphylm application is supported by 11 clinical studies involving 411 subjects, demonstrating pharmacokinetics comparable to epinephrine auto-injectors and a similar safety profile, Aquestive added.“As part of its ongoing review of the Company’s NDA for Anaphylm, the FDA notified us that it had identified deficiencies in the NDA that preclude discussion of labeling and post-marketing commitments at this time. Although the notification did not specify the deficiencies, Aquestive is working to understand and resolve the concerns. The FDA stated that the notification does not reflect a final decision on the pending application and the FDA’s review remains ongoing,” said Dan Barber, President and Chief Executive Officer of Aquestive.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the strong intraday decline, retail sentiment on Stocktwits for <a href="https://stocktwits.com/symbol/AQST">AQST</a> turned 'extremely bullish' from 'bullish' a day earlier, amid 'extremely high' message volumes.&nbsp;<img src="https://news.stocktwits-cdn.com/AQST_jpg_2de986106b.webp" alt="AQST.jpg">Over the past year, the stock has gained 23%.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Plug Power said it was impacted by the speed and development of hydrogen economy.

Why Did AQST Stock Plunge 40% In Pre-Market Today?

The company said the U.S. FDA identified deficiencies that prevent labeling discussions for a drug to treat allergic reactions.

AQST Stock Plunges On An FDA Setback For Its Allergy Drug – Here’s What Has Changed 

Equity

Should Vanguard S&P Small-Cap 600 Value ETF (VIOV) Be on Your Investing Radar?

Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?

Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?

Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?

Should Invesco S&P SmallCap Value with Momentum ETF (XSVM) Be on Your Investing Radar?

Should WisdomTree U.S. SmallCap ETF (EES) Be on Your Investing Radar?

Should Vanguard Small-Cap Value ETF (VBR) Be on Your Investing Radar?

Should iShares Russell 2000 Value ETF (IWN) Be on Your Investing Radar?

Shares of online payments company Paysafe (PSFE) slid over 14% in Tuesday’s pre-market session after its fourth-quarter <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.paysafe.com/news-events/press-releases/detail/238/paysafe-reports-fourth-quarter-and-full-year-2024-results">earnings</a> and full-year 2025 guidance failed to meet Wall Street expectations.For the fourth quarter (Q4), revenue increased 1% year-over-year (YoY) to $420.1 million compared to a Street estimate of $423.89 million, per Koyfin data. Adjusted earnings per share (EPS) dipped to $0.48 versus $0.66 last year and failed to beat an analyst estimate of $0.70.The company reported a net income of $33.5 million, compared to a net loss of $12.1 million in the same quarter a year ago. This reflected an increase in other income due to a gain on foreign exchange and an income tax benefit of $17.7 million.Paysafe said its Q4 results were significantly impacted by accelerated merchant exits and associated credit losses during the quarter, reflecting the company's strategic decision to reduce its exposure to direct marketing.This had an unfavorable impact on Q4 reported revenue growth for the total Paysafe and the Merchant Solutions segment of approximately three percentage points and five percentage points, respectively.CEO Bruce Lowthers highlighted that the company made significant progress, delivering on priorities and executing its three-year growth plan.“In 2025, our mission is clear: drive revenue through product innovation, improve sales efficiency, create new partnerships, and scale for better customer and employee experiences. With our foundational turnaround now behind us, we are looking forward to our third year of organic revenue growth,” he said.Passage’s guidance for 2025, however, failed to boost investment sentiment. The company projected a revenue of $1.710 billion to $1.734 billion for the year, lower than a Wall Street estimate of $1.79 billion.Paysafe expects adjusted EPS of $2.2 to $2.51 for the year, compared to an analyst estimate of $3.04.On Stocktwits, retail sentiment inched higher marginally but continued to trend in the ‘bearish’ territory (40/100).<figure class="image"><img style="aspect-ratio:1856/426;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_04_at_8_52_26_AM_4b1106679c.png" alt="PSFE’s Sentiment Meter and Message Volume as of 8:27 a.m. ET on 8:28 a.m. ET on March 4, 2025 | Source: Stocktwits" width="1856" height="426"><figcaption>PSFE’s Sentiment Meter and Message Volume as of 8:27 a.m. ET on 8:28 a.m. ET on March 4, 2025 | Source: Stocktwits</figcaption></figure>Paysafe also announced it has recently received unsolicited preliminary non-binding expressions of interest.The company said that its board remains confident in its prospects as a stand-alone company and in its ability to continue to create shareholder value. “However, in accordance with its fiduciary responsibilities, the Board, with its financial and legal advisors, will consider any proposals that maximize shareholder value,” the company noted.Paysafe also clarified that its board has not initiated a sale process and is only reviewing the unsolicited proposals.One Stocktwits user expressed disappointment at the results. &nbsp;<stembedurl>https://stocktwits.com/MBFG09/message/606651872</stembedurl><a href="https://stocktwits.com/symbol/PSFE">Paysafe shares</a> have risen over 11% in 2025 and gained over 34% in the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/citi-reportedly-makes-another-fund-transfer-error/chejlNuRC0">Citi Reportedly Made Another Fund Transfer Error In April 2024 Worth $6B: Retail’s On Wait-And-Watch Mode</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Paysafe Stock Tumbles Pre-Market After Disappointing Q4 Earnings, 2025 Guidance: Retail Stays Bearish

Paysafe said its Q4 results were significantly impacted by accelerated merchant exits and associated credit losses during the quarter.

IWN
iShares Russell 2000 Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWN News

IWNiShares Russell 2000 Value ETF